Verdier Eye Center, PLC is currently enrolling patients in a national study for the treatment of Keratoconus.  Keratoconus is a disease of the cornea that causes thinning and weakening of the corneal tissue. The study, entitled The Treatment of Keratoconus using Collagen Cross-linking, is a prospective, randomized, blinded study which will include a treatment group and a placebo group.  The treatment uses a combination of topical Riboflavin and UV light applied directly to the cornea.  Riboflavin and UV light work together to promote cross-linking of the corneal collagen fibrils, which we believe helps strengthen and stabilize the cornea.  Previous studies conducted in Italy and Germany have shown corneal flattening following treatment and a reduction in disease progression.  We are excited to be part of the continuing investigations in the United States.

If you are interested in learning more about the study or think you may be a candidate, please contact Paula at our office 616-949-2001.